US FDA and CDRH in 2020: Peering Out The Window

In this webinar, top regulatory consultant, John Avellanet, presented a look at potential changes facing FDA-regulated industry in the coming year. This is a critical moment at FDA with both the recent confirmation of a new FDA Commissioner and the looming election likely to impact the Agency’s regulatory and enforcement strategies.

This webinar addressed:

A look at the new FDA Commissioner, Dr. Stephen Hahn, a former radiation oncologist at MD Anderson Cancer Center;
Important regulatory changes and standards introduced in the past year; and
Insights into likely enforcement priorities for FDA in the year ahead.